IL-8 in Human Glioblastoma Tumors Instructs Immunosuppressive Myeloid Cells

Adult glioblastoma (GBM) is an aggressive brain tumor that has yet to benefit from advances in immunotherapy. Prior studies report contrasting leukocyte immunophenotypes between tumors and an association between myeloid macrophage infiltration and worse patient outcomes. IL-8, a cytokine with both inflammatory and suppressive roles, was recently associated with M2 macrophage phenotypes in GBM. These observations raise key questions: do GBM macrophages suppress or support other immune cells, is IL-8 in GBM a mechanistic driver of GBM macrophage function, and can IL-8 instruct macrophages in situ within tumors? Here, functional experiments with primary human GBM tumor cells from initial surgical resections showed that IL-8 from GBM contributes to and is sufficient to instruct monocyte-derived macrophages that suppress healthy T cells. Notably, IL-8 protein expression was enriched in aggressive tumors contacting the V-SVZ region and was not associated with increased infiltration of cells expressing the IL-8 receptors CXCR1/CXCR2. Suppressor cells instructed by GBM ex vivo phenotypically matched myeloid macrophages observed in vivo, and neutralizing IL-8 during instruction blocked this and restored T cell proliferation. Analysis of IL-8 RNA showed the cytokine is primarily produced by CD45- tumor cells. These results suggest a model where ongoing IL-8 production by GBM cells maintains an immunosuppressive microenvironment by signaling to myeloid macrophages within the tumor. Immunotherapies relying on T cells should now investigate whether IL-8 blockade prevents instruction of macrophages into tumor-protective suppressor cells.

Authors

Institutions

Publication Details

Journal
Cancer Immunology Research
Published
2026-11-12
DOI
https://doi.org/10.1158/2326-6066.cir-26-0415
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

IL-8 in Human Glioblastoma Tumors Instructs Immunosuppressive Myeloid Cells

Nicholas M. Negretti, Rebecca A. Ihrie, Stephanie Medina, Madeline Hayes et al.
Cancer Immunology Research
Immune cells in cancer
article

IL-8 in Human Glioblastoma Tumors Instructs Immunosuppressive Myeloid Cells

Nicholas M. Negretti, Rebecca A. Ihrie, Stephanie Medina, Madeline Hayes, Silky Chotai, Kyle D. Weaver, Jonathan Michael Irish, Asa A. Brockman, Akshitkumar M. Mistry, Jennifer M. S. Sucre, Reid C. Thompson, Lola Blackwell Chambless, Bret C. Mobley, Christopher S. Jetter, Claire E. Cross
article en

Abstract

Adult glioblastoma (GBM) is an aggressive brain tumor that has yet to benefit from advances in immunotherapy. Prior studies report contrasting leukocyte immunophenotypes between tumors and an association between myeloid macrophage infiltration and worse patient outcomes. IL-8, a cytokine with both inflammatory and suppressive roles, was recently associated with M2 macrophage phenotypes in GBM. These observations raise key questions: do GBM macrophages suppress or support other immune cells, is IL-8 in GBM a mechanistic driver of GBM macrophage function, and can IL-8 instruct macrophages in situ within tumors? Here, functional experiments with primary human GBM tumor cells from initial surgical resections showed that IL-8 from GBM contributes to and is sufficient to instruct monocyte-derived macrophages that suppress healthy T cells. Notably, IL-8 protein expression was enriched in aggressive tumors contacting the V-SVZ region and was not associated with increased infiltration of cells expressing the IL-8 receptors CXCR1/CXCR2. Suppressor cells instructed by GBM ex vivo phenotypically matched myeloid macrophages observed in vivo, and neutralizing IL-8 during instruction blocked this and restored T cell proliferation. Analysis of IL-8 RNA showed the cytokine is primarily produced by CD45- tumor cells. These results suggest a model where ongoing IL-8 production by GBM cells maintains an immunosuppressive microenvironment by signaling to myeloid macrophages within the tumor. Immunotherapies relying on T cells should now investigate whether IL-8 blockade prevents instruction of macrophages into tumor-protective suppressor cells.

Cancer Immunology Research
University of Louisville (US), Vanderbilt University (US), University of Louisville Hospital (US), University of Colorado Anschutz Medical Campus (US), Vanderbilt University Medical Center (US)
Vanderbilt University, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, National Institutes of Health, National Cancer Institute
Good health and well-being
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon